Literature DB >> 861153

Do sympathomimetic amines prevent exercise-induced asthma by bronchodilatation alone?

M R Hetzel, J C Batten, T J Clark.   

Abstract

Seventeen patients with exercise-induced asthma were studied. Eleven patients (cases 7-17), of whom seven were atopic subjects, were given isoetharine or isoprenaline and were subsequently tested for exercise-induced asthma after bronchodilatation had ceased. In two atopic and one non-atopic patients protection was observed which could not be attributed to chance. Two of these three patients were studied again and this phenomenon was repeatable. Prevention of exercise-induced asthma 30 min after inhalation of isoetherine and sodium cromoglycate was compared in 10 patients (cases 1-10), of whom six were atopic subjects. There was no significant difference in the results and protection from isoetharine was not related to the magnitude of its bronchodilator effect. These results suggest that beta-adrenergic agonists may have both bronchodilator and other actions in exercise-iduced asthma. Whether these other actions are anti-alergic is unknown.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861153     DOI: 10.1016/0007-0971(77)90091-2

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  5 in total

1.  Exercise-induced asthma.

Authors: 
Journal:  Br Med J       Date:  1977-08-27

2.  Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.

Authors:  K R Patel
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

Review 3.  A more logical approach to asthma.

Authors:  M R Hetzel
Journal:  Postgrad Med J       Date:  1984-03       Impact factor: 2.401

4.  Exercise-induced asthma.

Authors: 
Journal:  Br Med J       Date:  1980-02-02

5.  Prevention of exercise induced asthma by inhaled salmeterol xinafoate.

Authors:  C P Green; J F Price
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.